Search for Clinical Trial Results

Sponsored By

Encephalomyelitis - 25 Studies Found

Status Study
Completed Study Name: Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Condition:
  • Acute Disseminated Encephalomyelitis
  • Devic's Syndrome
  • Date: 2000-02-24
    Interventions: Procedure: Plasma exchange
Active, not recruiting Study Name: Biobank For MS And Other Demyelinating Diseases
Condition:
  • Multiple Sclerosis
  • Transverse Myelitis
  • Neuromyelitis Optic
    Date: 2007-03-08
Enrolling by invitation Study Name: Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine
Condition: Venezuelan Equine Encephalomyelitis
Date: 2007-12-19
Interventions: Biological: VEE TC-83 Subjects will receive a single 0.5 mL dose by subcutaneous route in the upper oute
Recruiting Study Name: Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
Condition:
  • Fatigue Syndrome, Chronic
  • Myalgic Encephalomyelitis

Date: 2016-12-19
Interventions:
  • Dietary Supplement: melatonin plus zinc

Completed Study Name: The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
Condition:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis

Date: 2005-09-16
Interventions: Drug: Ampligen
Terminated Study Name: Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
Condition:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis

Date: 2012-11-08
Interventions: Drug: Etanercept Weekly subcutaneous injections of Etanercept 50 mg, for up to 12 months.
Recruiting Study Name: Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
Condition:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis
  • Date: 2016-07-29
    Interventions:
    • Drug: Normal Saline 1 liter of
Recruiting Study Name: Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health
Condition: Chronic Fatigue Syndrome
Date: 2016-01-29
Terminated Study Name: B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome
Condition:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis

Date: 2010-07-02
Interventions: Drug: Rituximab Two infusions of Rituximab 500 mg/m2 (max
Completed Study Name: B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
Condition:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis

Date: 2010-07-02
Interventions: Drug: Rituximab Two infusions of Rituximab 500 mg/m2 (max
Next >>>